======= NRIP1 =======
== Gene Information ==
* **Official Symbol**: NRIP1
* **Official Name**: nuclear receptor interacting protein 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8204|8204]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P48552|P48552]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NRIP1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NRIP1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602490|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: Nuclear receptor interacting protein 1 (NRIP1) is a nuclear protein that specifically interacts with the hormone-dependent activation domain AF2 of nuclear receptors. Also known as RIP140, this protein modulates transcriptional activity of the estrogen receptor. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Modulates transcriptional activation by steroid receptors such as NR3C1, NR3C2 and ESR1. Also modulates transcriptional repression by nuclear hormone receptors. Positive regulator of the circadian clock gene expression: stimulates transcription of ARNTL/BMAL1, CLOCK and CRY1 by acting as a coactivator for RORA and RORC. {ECO:0000269|PubMed:10364267, ECO:0000269|PubMed:11509661, ECO:0000269|PubMed:11518808, ECO:0000269|PubMed:12554755, ECO:0000269|PubMed:15060175, ECO:0000269|PubMed:21628546, ECO:0000269|PubMed:7641693}.
No Pfam Domain information is available for this gene.
|ovarian follicle rupture|
|ovulation from ovarian follicle|
|glucocorticoid receptor binding|
|retinoid X receptor binding|
|ovulation|
|nuclear hormone receptor binding|
|lipid storage|
|cellular response to estradiol stimulus|
|androgen receptor signaling pathway|
|histone deacetylase complex|
|ovulation cycle process|
|estrogen receptor binding|
|androgen receptor binding|
|circadian regulation of gene expression|
|ovulation cycle|
|intracellular steroid hormone receptor signaling pathway|
|female gonad development|
|development of primary female sexual characteristics|
|female sex differentiation|
|histone deacetylase binding|
|steroid hormone mediated signaling pathway|
|female gamete generation|
|response to estradiol|
|circadian rhythm|
|intracellular receptor signaling pathway|
|maintenance of location|
|hormone-mediated signaling pathway|
|cellular response to steroid hormone stimulus|
|gonad development|
|development of primary sexual characteristics|
|nuclear chromatin|
|transcription corepressor activity|
|sex differentiation|
|rhythmic process|
|transcription coactivator activity|
|lipid localization|
|response to steroid hormone|
|nuclear speck|
|reproductive structure development|
|reproductive system development|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|cellular response to lipid|
|cellular response to organic cyclic compound|
|cellular response to hormone stimulus|
|developmental process involved in reproduction|
|gamete generation|
|multicellular organismal reproductive process|
|sexual reproduction|
|multicellular organism reproduction|
|response to lipid|
|nucleolus|
|negative regulation of transcription by RNA polymerase II|
|response to hormone|
|response to organic cyclic compound|
|multi-organism reproductive process|
|cellular response to oxygen-containing compound|
|negative regulation of transcription, DNA-templated|
|positive regulation of transcription by RNA polymerase II|
|cellular response to endogenous stimulus|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|reproductive process|
|reproduction|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|response to endogenous stimulus|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|response to oxygen-containing compound|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp477|DKK1 89ng/ml R08 exp477]]|-1.7|
|[[:results:exp42|BI-6727 0.001μM R01 exp42]]|2.11|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15914
* **Expression level (log2 read counts)**: 6.06
{{:chemogenomics:nalm6 dist.png?nolink |}}